Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Junlin Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise headquartered in the Shijiazhuang High-tech Industrial Development Zone, China. Established in 2004, the company integrates drug research and development with large-scale manufacturing and domestic distribution. Its commercial portfolio includes a wide range of dosage forms such as tablets, capsules, granules, and injections, primarily focusing on therapeutic areas like respiratory health, anti-infectives, and cardiovascular medicine. The company operates multiple production lines certified under Chinese Good Manufacturing Practice (GMP) standards. Hebei Junlin is a significant contributor to the regional pharmaceutical supply chain, providing high-quality generic medications to the Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Junlin Pharmaceutical.